Reliable and reproducible Monocyte Activation Test

Published: 9-Oct-2017

Sanquin Reagents has developed a reliable and reproducible Monocyte Activation Test (MAT), which can replace rabbit testing for measuring endotoxin and non-endotoxin pyrogens

At the PharmaLab Congress 7–8 November 2017 in Dusseldorf, Sanquin will present the latest news on the Monocyte Activation Test, which is now commercially available in the MAT Cell Set.

Delegates can attend the Sanquin lecture presented by Dr Astrid Visser on 8 November 2.45 pm in the endotoxin and pyrogen section or visit Sanquin in the exhibition hall at stand 13.

A limited number of free one day entrance tickets (value 690 €) are available, please use the form to apply.

Sanquin Reagents closely co-operates with the divisions Research, Diagnostic Services, Plasma Products and Blood Bank. This combination of expertise has resulted in a unique setting for the development, production and support of MAT, which is available in the form of an assay kit and services.

  • Companies:
  • Sanquin Reagents
See more

You may also like

Analysis

Sanquin to exhibit at PDA Europe

Read more
Meet the team to discover its new test kit and test-service based on cryopreserved PBMCs and IL-6 read outs

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be complicated. Here, the tablet experts Natoli explain how to develop tabletability, compactibility, and compressibility profiles
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Analysis

Sanquin to exhibit at PDA Europe

Meet the team to discover its new test kit and test-service based on cryopreserved PBMCs and IL-6 read outs
Analysis

Sanquin exhibits at Pharmalab Congress

Sanquin is the first company worldwide to introduce a test kit and test-service based on cryopreserved PBMCs and IL-6 read outs
Research & Development

Sanquin contributes to European research against MS

Sanquin researchers Dr Anja ten Brinke and Professor Marieke van Ham take part in a European consortium that aims to find a cure for multiple sclerosis

New worldwide exclusive license and collaboration for immuno-oncology therapeutic leads

Synthon Biopharmaceuticals BV, an international biopharmaceutical company that is focused on developing new molecular entities for treating cancer and autoimmune diseases, has announced a new license and collaboration agreement for the development of novel immuno-oncology antibodies with Sanquin Blood Supply Foundation (‘Sanquin’), Amsterdam
Research & Development

Compact process thermostat for efficient temperature control in the laboratory

The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
Drug Delivery

Adult vaccination programmes deliver significant socio-economic benefits, study finds

The study shows that adult immunisation programmes return 19x their initial investment, which could ease the pressure on health systems
Cell & Gene Therapy

AviadoBio expands presence at Canary Wharf

The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Subscribe now